Design Therapeutics Stock Price Patterns
| DSGN Stock | USD 10.39 0.01 0.1% |
Momentum 61
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.34) | EPS Estimate Current Year (1.30) | EPS Estimate Next Year (1.30) | Wall Street Target Price 14.4 |
Using Design Therapeutics hype-based prediction, you can estimate the value of Design Therapeutics from the perspective of Design Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Design Therapeutics using Design Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Design using crowd psychology based on the activity and movement of Design Therapeutics' stock price.
Design Therapeutics Implied Volatility | 2.76 |
Design Therapeutics' implied volatility exposes the market's sentiment of Design Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Design Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Design Therapeutics stock will not fluctuate a lot when Design Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Design Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Design because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Design Therapeutics after-hype prediction price | USD 10.16 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Design contract
Based on the Rule 16, the options market is currently suggesting that Design Therapeutics will have an average daily up or down price movement of about 0.17% per day over the life of the 2026-04-17 option contract. With Design Therapeutics trading at USD 10.39, that is roughly USD 0.0179 . If you think that the market is fully incorporating Design Therapeutics' daily price movement you should consider acquiring Design Therapeutics options at the current volatility level of 2.76%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Design Therapeutics Basic Forecasting Models to cross-verify your projections. Design Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Design Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Design Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Design Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Design Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Design Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Design Therapeutics' historical news coverage. Design Therapeutics' after-hype downside and upside margins for the prediction period are 5.78 and 14.54, respectively. We have considered Design Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Design Therapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Design Therapeutics is based on 3 months time horizon.
Design Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Design Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Design Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Design Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.61 | 4.38 | 0.23 | 0.07 | 10 Events / Month | 2 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
10.39 | 10.16 | 2.21 |
|
Design Therapeutics Hype Timeline
Design Therapeutics is currently traded for 10.39. The entity has historical hype elasticity of -0.23, and average elasticity to hype of competition of 0.07. Design is forecasted to decline in value after the next headline, with the price expected to drop to 10.16. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.21%, whereas the daily expected return is currently at 0.61%. The volatility of related hype on Design Therapeutics is about 3590.16%, with the expected price after the next announcement by competition of 10.46. About 36.0% of the company shares are held by company insiders. The book value of Design Therapeutics was currently reported as 3.51. The company recorded a loss per share of 1.19. Design Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Design Therapeutics Basic Forecasting Models to cross-verify your projections.Design Therapeutics Related Hype Analysis
Having access to credible news sources related to Design Therapeutics' direct competition is more important than ever and may enhance your ability to predict Design Therapeutics' future price movements. Getting to know how Design Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Design Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GOVX | GeoVax Labs | 0.65 | 8 per month | 0.00 | (0.28) | 9.38 | (13.70) | 42.89 | |
| BLRX | BioLineRx | 0.05 | 7 per month | 0.00 | (0.06) | 5.20 | (5.26) | 13.04 | |
| THAR | Tharimmune | (0.15) | 9 per month | 5.92 | 0.08 | 11.55 | (10.08) | 40.06 | |
| AIMD | Ainos Inc | 0.06 | 9 per month | 0.00 | (0.11) | 12.30 | (10.43) | 38.73 | |
| LPCN | Lipocine | 0.00 | 6 per month | 3.28 | 0.30 | 15.95 | (7.33) | 33.09 |
Design Therapeutics Additional Predictive Modules
Most predictive techniques to examine Design price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Design using various technical indicators. When you analyze Design charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Design Therapeutics Predictive Indicators
The successful prediction of Design Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Design Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Design Therapeutics based on analysis of Design Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Design Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Design Therapeutics's related companies. | 2025 | 2026 (projected) | Interest Debt Per Share | 0.0371 | 0.0426 | Revenue Per Share | 2.8E-5 | 2.5E-5 |
Pair Trading with Design Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Design Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Design Stock
Moving against Design Stock
| 0.77 | GNLX | Genelux Common | PairCorr |
| 0.72 | EVGN | Evogene | PairCorr |
| 0.71 | EDIT | Editas Medicine | PairCorr |
| 0.68 | QSI | QuantumSi | PairCorr |
| 0.67 | LYRA | Lyra Therapeutics | PairCorr |
| 0.64 | IMRN | Immuron Ltd ADR | PairCorr |
The ability to find closely correlated positions to Design Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Design Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Design Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Design Therapeutics to buy it.
The correlation of Design Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Design Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Design Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Design Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Design Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Design Stock, please use our How to Invest in Design Therapeutics guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Will Biotechnology sector continue expanding? Could Design diversify its offerings? Factors like these will boost the valuation of Design Therapeutics. Projected growth potential of Design fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Design Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Design Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Design Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Design Therapeutics' market price to deviate significantly from intrinsic value.
It's important to distinguish between Design Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Design Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Design Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.